In this edition, splash pads reduce child drowning risk but boost diarrhea outbreaks; FDA approves Konvomep for benign gastric ulcers; Xifaxan generic may be stalled until 2029 and more.
Read the full coverage here:
‘The water is recycled’: Splash pads reduce child drowning risk, boost diarrhea outbreaks
FDA approves Konvomep for benign gastric ulcers, risk reduction for upper GI bleeding
Xifaxan generic may be stalled until 2029 despite tentative FDA approval
Earlier CRC screening with colonoscopy, FIT cost-effective ‘irrespective of BMI’
1-year surveillance endoscopy recommended for patients at high risk for gastric cancer
References:
Aluko SK, et al. MMWR Morb Mortal Wkly Rep. 2022;doi:10.15585/mmwr.mm7131a1
Yamamoto Y, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.27667.
Yeoh A, et al. Clin Gastroenterol Hepatol. 2022;doi:10.1016/j.cgh.2022.07.028.
